• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Lesson learnt from 60 years of liver transplantation: Advancements, challenges, and future directions.从60年肝移植中汲取的经验教训:进展、挑战与未来方向。
World J Transplant. 2025 Mar 18;15(1):93253. doi: 10.5500/wjt.v15.i1.93253.
2
Perspectives and Tools in Liver Graft Assessment: A Transformative Era in Liver Transplantation.肝脏移植评估的视角与工具:肝脏移植的变革时代
Biomedicines. 2025 Feb 17;13(2):494. doi: 10.3390/biomedicines13020494.
3
Progress of pediatric liver transplantation: In Japan and beyond.小儿肝移植的进展:日本及其他地区
Chin Med J (Engl). 2025 Apr 20;138(8):894-904. doi: 10.1097/CM9.0000000000003520. Epub 2025 Mar 27.
4
The impact of artificial intelligence and machine learning in organ retrieval and transplantation: A comprehensive review.人工智能和机器学习在器官获取与移植中的影响:全面综述
Curr Res Transl Med. 2025 Jan 6;73(2):103493. doi: 10.1016/j.retram.2025.103493.
5
Has the risk of liver re-transplantation improved over the two decades?在过去二十年中,肝脏再次移植的风险有所改善吗?
Clin Transplant. 2023 Dec;37(12):e15127. doi: 10.1111/ctr.15127. Epub 2023 Sep 29.
6
Liver Transplantation Update: 2014.《肝脏移植最新进展:2014年》
Euroasian J Hepatogastroenterol. 2015 Jul-Dec;5(2):98-106. doi: 10.5005/jp-journals-10018-1144. Epub 2016 Jul 9.
7
Ethics and Algorithms to Navigate AI's Emerging Role in Organ Transplantation.伦理与算法:应对人工智能在器官移植中日益凸显的作用
J Clin Med. 2025 Apr 17;14(8):2775. doi: 10.3390/jcm14082775.
8
Artificial Intelligence and Robotics in Transplant Surgery: Advancements and Future Directions.移植手术中的人工智能与机器人技术:进展与未来方向
Cureus. 2023 Aug 23;15(8):e43975. doi: 10.7759/cureus.43975. eCollection 2023 Aug.
9
Liver Transplantation: East versus West.肝移植:东方与西方
J Clin Exp Hepatol. 2013 Sep;3(3):243-53. doi: 10.1016/j.jceh.2013.08.004. Epub 2013 Sep 12.
10
Current status of liver transplantation in children.儿童肝移植的现状
Pediatr Clin North Am. 2003 Dec;50(6):1335-74. doi: 10.1016/s0031-3955(03)00150-0.

引用本文的文献

1
Transjugular intrahepatic portosystemic shunt and non-selective beta-blockers act as friends or foe in decompensated cirrhosis: A comparative review.经颈静脉肝内门体分流术与非选择性β受体阻滞剂在失代偿期肝硬化中是“友”还是“敌”:一项比较性综述
World J Gastrointest Surg. 2025 Apr 27;17(4):103395. doi: 10.4240/wjgs.v17.i4.103395.

本文引用的文献

1
Transplant oncology - Current indications and strategies to advance the field.移植肿瘤学——推动该领域发展的当前适应症和策略。
JHEP Rep. 2023 Nov 16;6(2):100965. doi: 10.1016/j.jhepr.2023.100965. eCollection 2024 Feb.
2
Prolonged hypothermic machine perfusion enables daytime liver transplantation - an IDEAL stage 2 prospective clinical trial.延长低温机器灌注可实现日间肝移植——一项IDEAL 2期前瞻性临床试验
EClinicalMedicine. 2024 Jan 5;68:102411. doi: 10.1016/j.eclinm.2023.102411. eCollection 2024 Feb.
3
Complications in Post-Liver Transplant Patients.肝移植术后患者的并发症
J Clin Med. 2023 Sep 24;12(19):6173. doi: 10.3390/jcm12196173.
4
Predicting post-liver transplant outcomes in patients with acute-on-chronic liver failure using Expert-Augmented Machine Learning.使用专家增强机器学习预测慢加急性肝衰竭患者肝移植术后结局。
Am J Transplant. 2023 Dec;23(12):1908-1921. doi: 10.1016/j.ajt.2023.08.022. Epub 2023 Aug 30.
5
Evolving Landscape in Liver Transplantation for Hepatocellular Carcinoma: From Stage Migration to Immunotherapy Revolution.肝细胞癌肝移植的发展态势:从分期迁移到免疫治疗革命
Life (Basel). 2023 Jul 14;13(7):1562. doi: 10.3390/life13071562.
6
Computed Tomography and Magnetic Resonance Imaging Signs of Chronic Liver Rejection: A Case-Control Study.计算机断层扫描和磁共振成像对慢性肝排斥反应的征象:病例对照研究。
J Comput Assist Tomogr. 2024;48(1):26-34. doi: 10.1097/RCT.0000000000001511. Epub 2023 Jul 7.
7
Diabetes and Metabolic Disorders: Their Impact on Cardiovascular Events in Liver Transplant Patients.糖尿病和代谢紊乱:它们对肝移植患者心血管事件的影响。
Can J Gastroenterol Hepatol. 2023 Jun 23;2023:2199193. doi: 10.1155/2023/2199193. eCollection 2023.
8
Case Report: Successful liver transplantation after achieving complete clinical remission of advanced HCC with Atezolizumab plus Bevacizumab combination therapy.病例报告:阿替利珠单抗联合贝伐珠单抗治疗晚期 HCC 达到完全临床缓解后成功进行肝移植。
Front Immunol. 2023 Jun 12;14:1205997. doi: 10.3389/fimmu.2023.1205997. eCollection 2023.
9
Successful advanced hepatocellular carcinoma downstaging with atezolizumab-Bevacizumab and radioembolization before liver transplantation.在肝移植前使用阿替利珠单抗-贝伐单抗和放射性栓塞成功使晚期肝细胞癌降期。
Clin Res Hepatol Gastroenterol. 2023 Aug;47(7):102167. doi: 10.1016/j.clinre.2023.102167. Epub 2023 Jun 19.
10
Artificial intelligence, machine learning, and deep learning in liver transplantation.人工智能、机器学习和深度学习在肝移植中的应用。
J Hepatol. 2023 Jun;78(6):1216-1233. doi: 10.1016/j.jhep.2023.01.006.

从60年肝移植中汲取的经验教训:进展、挑战与未来方向。

Lesson learnt from 60 years of liver transplantation: Advancements, challenges, and future directions.

作者信息

Gadour Eyad

机构信息

Department of Gastroenterology and Hepatology, King Abdulaziz National Guard Hospital, Ahsa 36428, Saudi Arabia.

Internal Medicine, Zamzam University College, Khartoum 11113, Sudan.

出版信息

World J Transplant. 2025 Mar 18;15(1):93253. doi: 10.5500/wjt.v15.i1.93253.

DOI:10.5500/wjt.v15.i1.93253
PMID:40104199
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11612893/
Abstract

Over the past six decades, liver transplantation (LT) has evolved from an experimental procedure into a standardized and life-saving intervention, reshaping the landscape of organ transplantation. Driven by pioneering breakthroughs, technological advancements, and a deepened understanding of immunology, LT has seen remarkable progress. Some of the most notable breakthroughs in the field include advances in immunosuppression, a revised model for end-stage liver disease, and artificial intelligence (AI)-integrated imaging modalities serving diagnostic and therapeutic roles in LT, paired with ever-evolving technological advances. Additionally, the refinement of transplantation procedures, resulting in the introduction of alternative transplantation methods, such as living donor LT, split LT, and the use of marginal grafts, has addressed the challenge of organ shortage. Moreover, precision medicine, guiding personalized immunosuppressive strategies, has significantly improved patient and graft survival rates while addressing emergent issues, such as short-term complications and early allograft dysfunction, leading to a more refined strategy and enhanced post-operative recovery. Looking ahead, ongoing research explores regenerative medicine, diagnostic tools, and AI to optimize organ allocation and post-transplantation car. In summary, the past six decades have marked a transformative journey in LT with a commitment to advancing science, medicine, and patient-centered care, offering hope and extending life to individuals worldwide.

摘要

在过去的六十年里,肝移植(LT)已从一种实验性手术发展成为一种标准化的、挽救生命的干预措施,重塑了器官移植的格局。在开创性突破、技术进步以及对免疫学的深入理解的推动下,肝移植取得了显著进展。该领域一些最显著的突破包括免疫抑制方面的进展、终末期肝病修订模型以及在肝移植中发挥诊断和治疗作用的人工智能(AI)集成成像模式,同时伴随着不断发展的技术进步。此外,移植手术的完善,带来了如活体供体肝移植、劈离式肝移植以及使用边缘供肝等替代移植方法的引入,解决了器官短缺的挑战。此外,精准医学指导个性化免疫抑制策略,在解决诸如短期并发症和早期移植肝功能障碍等紧急问题的同时,显著提高了患者和移植肝的存活率,从而形成了更精细的策略并促进了术后恢复。展望未来,正在进行的研究探索再生医学、诊断工具和人工智能,以优化器官分配和移植后护理。总之,过去六十年标志着肝移植领域的变革之旅,致力于推动科学、医学以及以患者为中心的护理,为全球各地的人们带来希望并延长生命。